HealthQuill Acquisition
Johnson & Johnson will buy Ambrx Biopharma, Inc., a company developing targeted chemotherapy treatments, for $2 billion in cash.
Drugs Health Pharma

J&J to purchase Ambrx Biopharma for $2 billion in all-cash deal

HQ Team January 8, 2023: Johnson & Johnson will buy Ambrx Biopharma, Inc., a company developing targeted chemotherapy treatments, for $2 billion in cash..

Read More
Bristol Myers Squibb will buy US-based biotech company, Karuna Therapeutics for $14 billion to expand its neuroscience portfolio, the companies announced.
Drugs Health Pharma

Bristol Myers to acquire Karuna Therapeutics for $14 billion

HQ Team December 23, 2023: Bristol Myers Squibb will buy US-based biotech company, Karuna Therapeutics for $14 billion to expand its neuroscience portfolio,.

Read More
Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring its business and management.
Drugs Health Pharma

Pfizer revamps organisation as $43 billion Seagen deal comes to close

HQ Team December 13, 2023: Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring.

Read More
AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to boost the North Chicago, Illinois-based company’s presence in the psychiatric and neurological disorder segment.
Drugs Health Pharma

AbbVie to acquire Cerevel for $8.7b to bolster neurological treatments

HQ Team December 7, 2023: AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to.

Read More
AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to acquire ImmunoGen, Inc., for $10.1 billion. Image Credit: AbbVie
Drugs Health Pharma

AbbVie to buy Immunogen for $10.1b to expand solid tumour market

HQ Team November 30, 2023: AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to.

Read More
Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have approved a plan from US’s Danaher Corp to acquire the company for $5.7 billion.
Drugs Health Pharma

Abcam shareholders approve Danaher Corp acquisition for $5.7 billion

HQ Team November 7, 2023: Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have.

Read More
Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through a combination of cash and debt to broaden its cancer portfolio.
Drugs Health Pharma

Bristol Myers acquires Mirati Therapeutics for $5.8 billion

HQ Team October 9, 2023: Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through.

Read More
Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two drugs that treat rare inflammatory diseases.
Drugs Health Pharma

Amgen completes $27.8b acquisition of Horizon Therapeutics

Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two.

Read More
Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its product portfolio.
Health Medical Pharma

Cordis acquires medical device maker MedAlliance for $1.1 billion

HQ Team October 2, 2023: Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its.

Read More
Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in the US for $7.7  million.
Drugs Health Pharma

Biocon buys Eywa Pharma’s US facility for $7.7 million

HQ Team September 6, 2023: Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in.

Read More